{
  "id": "61f7d4da882a024a10000033",
  "type": "yesno",
  "question": "Is there an association between Guillain\u2013Barr\u00e9 syndrome and covid vaccine?",
  "ideal_answer": "Yes. There series reporting Guillain\u2013Barr\u00e9 syndrome after COVID-19 vaccination.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34484780",
    "http://www.ncbi.nlm.nih.gov/pubmed/34306190",
    "http://www.ncbi.nlm.nih.gov/pubmed/34330729",
    "http://www.ncbi.nlm.nih.gov/pubmed/34649856",
    "http://www.ncbi.nlm.nih.gov/pubmed/34560365",
    "http://www.ncbi.nlm.nih.gov/pubmed/34418708",
    "http://www.ncbi.nlm.nih.gov/pubmed/34648420",
    "http://www.ncbi.nlm.nih.gov/pubmed/34617967",
    "http://www.ncbi.nlm.nih.gov/pubmed/34548920",
    "http://www.ncbi.nlm.nih.gov/pubmed/32896460",
    "http://www.ncbi.nlm.nih.gov/pubmed/34187803",
    "http://www.ncbi.nlm.nih.gov/pubmed/34538679",
    "http://www.ncbi.nlm.nih.gov/pubmed/33968610"
  ],
  "snippets": [
    {
      "text": "AstraZeneca COVID-19 vaccine and Guillain- Barr\u00e9 Syndrome in Tasmania: A causal link?",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34560365",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Nearly all reported cases of post-COVID-19 vacciation inflammatory demyelinating polyneuropathy are linked to AstraZeneca vaccination and a variant with bifacial weakness is the most reported form of GBS globally.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34560365",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Guillain-Barr\u00e9 Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34538679",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "CASE REPORT: We report a case of atypical GBS occurring after Coronavirus disease 2019 (COVID-19) vaccination in an otherwise healthy 38-year-old man.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34538679",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "It is critical for emergency physicians to be aware of the manifold presentations of GBS for early recognition and treatment. This may be of particular importance in the context of a worldwide vaccination campaign in response to the COVID-19 pandemic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34538679",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Guillain-Barr\u00e9 syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: A case series.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34548920",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We report three patients who developed Guillain-Barr\u00e9 syndrome following ChAdOx1 nCoV-19 vaccination, who did not have active or prior COVID-19 infection. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34548920",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We report a case of Guillain-Barr\u00e9\u00a0syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID-19 vaccine with papilledema as atypical onset.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34418708",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We report a case of Guillain-Barr\u00e9 syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34330729",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Guillain-\u200bBarr\u00e9 Syndrome Associated with COVID-19 Vaccination",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34648420",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Guillain-\u200bBarr\u00e9 Syndrome Associated with COVID-19 Vaccination.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34648420",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To date, cases of Guillain-Barr\u00e9 syndrome (GBS) following a COVID vaccine (Pfizer, Johnson & Johnson, Janssen, AstraZeneca) have been reported.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34649856",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34187803",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We report a case of Guillain-Barr\u00e9 syndrome after the first dose of SARS-CoV-2 vaccine and believe this is a temporal, rather than causal association.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33968610",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34484780",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barr\u00e9 Syndrome, February-July 2021.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34617967",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Guillain-Barr\u00e9 syndrome associated with Covid-19: A close relationship or just a coincidence? (Review).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34306190",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Relation between COVID-19 and Guillain-Barr\u00e9 syndrome in adults. Systematic review.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32896460",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Guillain-Barr\u00e9 syndrome after COVID-19 vaccination.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34330729",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}